Post by
biggdogg on Mar 04, 2024 11:06am
API Partnership
These are the types of agreements that will ensure they get financed. They now have proven they have the ability to create new drugs, this is significant. They are truely transforming themselves into a major player on the biotech scene. The other aspect is API is not for profit, therefore their drug development will be low cost compared to traditional programs. I do like the fact they are going to make new barium contrast, going to market in the US with new drugs will bring big value down the road. The new vanadium MRI drug is going to make this stock fly. A great partnership with an Edmonton based company that has all the labs and personel to go from pre-clinical through phased trials. Fantastic!!
Comment by
postie1 on Mar 04, 2024 11:33am
Do not forget the C60 health product because if it is a reasonable price that could generate many dollars.
Comment by
lscfa on Mar 04, 2024 2:13pm
I read the NR as API doing only the regulatory work for Carbon based contrast products. VM and RC will do the drug development work.